NCT06006273 2025-11-10
A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Recruiting
Clinical Trials
5 trialsNCT03810742 2023-11-18
Nanoliposomal Irinotecan (Nal-IRI, ONIVYDE®) in Combination With TAS-102 (LONSURF®) in Refractory Solid Tumors
PharmaEngine
Phase 1 Completed
NCT00914914 2014-10-28
Safety Study of a Cell Penetrating Peptide (p28) to Treat Solid Tumors That Resist Standard Methods of Treatment
CDG Therapeutics, Inc.
Phase 1 Completed
NCT00759928 2014-07-02
PK Trial of Sorafenib & Erlotinib in Patients With Refractory Solid Tumors
SCRI Development Innovations, LLC
Phase 1 Completed
NCT00394446 2008-02-13
Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid Tumors
Myrexis Inc.
Phase 1 Completed